Funding for this research was provided by:
Instituto de Salud Carlos III (PI11/01960; PI14/01997; PI17/01556, PI14/00228; PI17/01503, CB07708/0012)
Ministerio de Economía y Competitividad (SAF2015-65019-R)
Miguel Servet tenure-track from the Fondo de Investigación Sanitaria (FIS) co-financed by European Union (CP10/00438; CPII16/0008)
Ajuts per a projectes de recerca clínica de l’Hospital Universitari de Bellvitge (2011-PR143/11)
Text and Data Mining valid from 2019-08-16
First Online: 16 August 2019
Compliance with Ethical Standards
: All authors declare that they have no conflict of interest. NV is the recipient of grants “Ajuts per a projectes de recerca clínica de l’Hospital Universitari de Bellvitge (2011-PR143/11)” and of the project “PI11/01960; PI14/01997 and PI17/01556” funded by the Instituto de Salud Carlos III and co-funded by the European Union (ERDF, “A way to build Europe”). JV has funding from the Instituto de Salud Carlos III through the project PI14/00228 and PI17/01503 co-funded by the European Union (ERDF, “A way to build Europe”). SFV has funding from the Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund (ERDF) (SAF2015–65019-R). The Spanish Biomedical Research Center in Diabetes and Associated Metabolic Disorders (CIBERDEM) (CB07708/0012) is an initiative of the Instituto de Salud Carlos III. SFV acknowledges support from the Miguel Servet tenure-track program (CP10/00438 and CPII16/0008) from the Fondo de Investigación Sanitaria (FIS) co-financed by the ERDF.
: The study was conducted according to the principles of the Declaration of Helsinki.
: All patients included in the study signed an informed consent form approved by the institutional ethics committee.